|
 | Up a level |
Almond, Stephen and O'Donnell, Owen (2000) Cost analysis of the treatment of schizophrenia in the UK: a a simulation model comparing olanzapine, risperidone and haloperidol. Pharmacoeconomics, 17 (4). pp. 383-389. ISSN 1170-7690
Buskens, Erik, Heeg, Bart M, Knapp, Martin, van Aalast, Gerda, Dries, Pieter J T, de Haan, Lieuwe and van Hout, Ben A (2005) Modelling the treated course of schizophrenia: development of a discrete event simulation model. Pharmacoeconomics, 23 (s1). pp. 17-33. ISSN 1170-7690
Campbell, Catherine and Foulis, C. (2004) Creating contexts for effective home-based care of people living with HIV/AIDS. Curationis, 27 (3). pp. 5-14. ISSN 0379-8577
Duggan, Andy, Warner, Juliet, Knapp, Martin and Kerwin, Robert (2003) Modelling the impact of clozapine on suicide in patients with treatment-resistant schizophrenia in the UK. British journal of psychiatry, 182 (6). pp. 505-508. ISSN 0007-1250
Fernández, José-Luis, Montgomery, Stuart and Francois, Clément (2005) Evaluation of the cost effectiveness of Escitalopram versus Venlafaxine XR in major depressive disorder. Pharmacoeconomics, 23 (2). pp. 155-167. ISSN 1170-7690
Helfer, Ana Paula, Camargo, Aline Lins, Tavares, Noemia Urruth Leão, Kanavos, Panos and Bertoldi, Andréa Dâmaso (2012) Capacidade aquisitiva e disponibilidade de medicamentos para doenças crônicas no setor público. Revista Panamericana de salud pública / Pan American journal of public health, 31 (3). pp. 225-232. ISSN 1020-4989
Hong, Jihyung, Dilla, Tatiana and Arellano, Jorge (2009) A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain. BMC psychiatry, 9 (1). p. 15. ISSN 1471-244X
Izugbara, Chimaraoke O. and Wekesa, Eliud (2011) Beliefs and practices about antiretroviral medication: a study of poor urban Kenyans living with HIV/AIDS. Sociology of health & illness, 33 (6). pp. 869-883. ISSN 0141-9889
Jones, Rob, Sheehan, Bart, Phillips, Patrick and Knapp, Martin (2009) DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease: a multicentre RCT. Trials, 10 (57). ISSN 1745-6215
Kanavos, Panos (1999) Financing pharmaceuticals in transition. Croatian medical journal, 40 (June). pp. 244-259. ISSN 0353-9504
Kanavos, Panos, Costa-i-Font, Joan and Seeley, Elizabeth (2008) Competition in off-patent drug markets: issues, regulation and evidence. Economic policy, 23 (55). pp. 499-544. ISSN 0266-4658
Kanavos, Panos and Gemmill, Marin (2005) Pharmaceutical pricing and reimbursement in Europe. Scrip reports . Scrip, London.
Kanavos, Panos and Vandoros, Sotiris (2011) Drugs US: are prices too high?: measuring international pharmaceutical price differences. Significance, 8 (1). pp. 15-18. ISSN 1740-9705
King, Derek, Knapp, Martin, Thomas, P., Razzouk, D., Loze, J.-Y., Kan, H.J. and van Baardewijk, M. (2011) Cost-effectiveness analysis of aripiprazole vs standard-of-care in the management of community-treated patients with schizophrenia: STAR study. Current medical research and opinion, 27 (2). pp. 365-374. ISSN 0300-7995
Knapp, Martin, King, Derek, Pugner, Klaus and Lapuerta, Pablo (2004) Non-adherence to antipsychotic medication regimens: associations with resource use and costs. British journal of psychiatry, 184 (6). pp. 509-516. ISSN 0007-1250
Knapp, Martin, Locklear, Julie and Jarbrink, Krister (2009) Impact of psychotic relapse definitions in assessing drug efficacy and costs: comparison of quetiapine XR, olanzapine and paliperidone ER. Current medical research and opinion, 25 (7). pp. 1593-1603. ISSN 0300-7995
Knapp, Martin, Windmeijer, Frank, Brown, Jacqueline, Kontodimas, Stathis, Tzivelekis, Sypros, Haro, Josep Maria, Ratcliffe, Mark, Hong, Jihyung and Novick, Diego (2008) Cost-utility analysis of treatment with Olanzapine compared with other antipsychotic treatments in patients with schizophrenia in the Pan-European SOHO study. Pharmacoeconomics, 26 (4). pp. 341-358. ISSN 1170-7690
Le Grand, Julian (1997) Afterword. In: Oakley, Ann and Ashton, John, (eds.) The gift relationship: from human blood to social policy. London School of Economics and Political Science, London, UK. ISBN 0753012014
McCrone, Paul R., Chisholm, Daniel, Knapp, Martin, Hughes, Richard, Comi, Giancarlo, Dalakas, Marinos C., Illa, Isabel, Kilindireas, Costas, Nobile-Orazio, Eduardo, Swan, Anthony Victor, Van den Bergh, Peter and Willison, Hugh J. (2003) Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy. European journal of neurology, 10 (6). pp. 687-694. ISSN 1468-1331
McCrone, Paul R., Weeramanthri, Tara, Knapp, Martin R.J., Rushton, Alan, Trowell, Judith, Miles, Gillian and Kolvin, Israel (2005) Cost-effectiveness of individual versus group psychotherapy for sexually abused girls. Child and adolescent mental health, 10 (1). pp. 26-31. ISSN 1475-3588
McGuire, Alistair (2012) The European value-pricing game. Expert review of pharmacoeconomics & outcomes research, 12 (1). pp. 5-6. ISSN 1473-7167
McGuire, Alistair, Burke, T., Goldstein, J., Maniadakis, N. and Pettitt, D. (2000) Overview of the Arthritis Cost Consequence Evaluation System (ACCES): a pharmacoeconomic model for celecoxib. British journal of rheumatology, 39 (s2). pp. 33-42. ISSN 1462-0324
Ragan, C. Ian, Bard, Imre and Singh, Ilina (2013) What should we do about student use of cognitive enhancers?: an analysis of current evidence. Neuropharmacology, 64 . pp. 588-595. ISSN 0028-3908
Sado, Mitsuhiro, Knapp, Martin, Yamauchi, Keita , Fujisawa, Daisuke , So, Mirai , Nakagawa, Atsuo , Kikuchi, Toshiaki and Ono, Yutaka (2009) Cost-effectiveness of combination therapy versus antidepressant therapy for management of depression in Japan. Australian and New Zealand journal of psychiatry, 43 (6). pp. 539-547. ISSN 0004-8674
Singh, Ilina (2008) Beyond polemics: science and ethics of ADHD. Nature reviews neuroscience, 9 (12). pp. 957-964. ISSN 1471-003X
Sorenson, Corinna, Naci, Huseyin, Cylus, Jonathan and Mossialos, Elias (2011) Evidence of comparative efficacy should have a formal role in European drug approvals. British medical journal, 343 (7822). d4849-d4849. ISSN 0959-8138
Surguladze, Simon, Patel, Anita, Kerwin, Robert W, Knapp, Martin and Travis, Michael J (2005) Cost analysis of treating schizophrenia with amisulpride: naturalistic mirror image study. Progress in neuro-psychopharmacology and biological psychiatry, 29 (4). pp. 517-522. ISSN 0278-5846
Tinelli, Michela (2001) Menopausa e terapia ormonale sostitutiva: qualità di vita e farmacoeconomia. Farmacoeconomia news, 3 . pp. 15-20. ISSN 1126-4705
Tinelli, Michela (2001) Progetto pilota per la rilevazione delle prescrizioni farmaceutiche in Farmacia. Cronache Farmaceutiche , 4 . pp. 200-204. ISSN 0011-1783
Tinelli, Michela, Blenkinsopp, Alison and Bond, Christine (2011) Development, validation and application of a patient satisfaction scale for a community pharmacy medicines-management service. International journal of pharmacy practice, 19 (3). pp. 144-155. ISSN 0961-7671
Towse, A, Drummond, Michael and Sorenson, Corinna (2012) Measuring value: pharmacoeconomics theory and practice. In: Danzon, Patricia M. and Nicholson, Sean, (eds.) Oxford handbook on the economics of the biopharmaceutical industry. Oxford University Press, Oxford, UK, pp. 394-437. ISBN 9780199742998
Towse, Adrian, Drummond, Michael and Sorenson, Corinna (2011) Measuring value: pharmacoeconomics in theory and practice. Occasional paper, 11/03. Office of Health Economics.
Vandoros, Sotiris and Kanavos, Panos (2013) The generics paradox revisited: empirical evidence from regulated markets. Applied economics, 45 (22). pp. 3230-3239. ISSN 0003-6846
Vandoros, Sotiris and Stargardt, Tom (2013) Reforms in the Greek pharmaceutical market during the financial crisis. Health Policy, 109 (1). pp. 1-6. ISSN 0168-8510
Varol, Nebibe, Costa-i-Font, Joan and McGuire, Alistair (2012) Does adoption of pharmaceutical innovation respond to changes in the regulatory environment? Applied economic perspectives and policy, 34 (3). pp. 531-553. ISSN 2040-5790
